Aurora Cannabis (ACB) Notes Payables (2018 - 2025)

Aurora Cannabis (ACB) has reported Notes Payables for 8 consecutive years, with $44.3 million the latest figure, recorded in Q4 2025.

• Quarterly Notes Payables fell 23.5% year-over-year to $44.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.3 million (down 23.5% YoY) and the FY2025 annual result came in at $15.5 million, down 72.97% from the prior year.
• Notes Payables climbed to $44.3 million in Q4 2025 per ACB's latest filing, from $43.4 million in the prior quarter.
• Over the last five years, Notes Payables for ACB reached as high as $74.8 million in Q2 2021 and fell as low as $7.1 million in Q1 2023.
• A 5-year average of $39.3 million and a median of $42.9 million in 2021 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2021 — Notes Payables plunged 76.81% — and 2024, when it jumped 448.87%.
• Year by year, Notes Payables stood at $30.1 million in 2021, then retreated by 11.39% to $26.6 million in 2022, then soared by 79.89% to $47.9 million in 2023, then advanced by 20.84% to $57.9 million in 2024, then slipped by 23.5% to $44.3 million in 2025.
• According to Business Quant data, Notes Payables over the past three periods registered $44.3 million, $43.4 million, and $43.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.